Bank of America, in a Thursday note, flagged a “rare (disease) opportunity,” as it initiated coverage on a biotech stock ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE